Injection:Article Title: Case study: risk associated to wearing silver or graphene nanoparticle-coated facemasks for protection against COVID-19
Article Snippet: in diameter (presumably GQD-PEG bioaccumulation) Blood biochemistry and haematology suggest no obvious toxicity of GQD-PEG , Chong et al. . .. 2 , Graphene oxide nanopowder (thickness 1 ~ 2 atom layer) Sprague–Dawley rats 15 males/group 0, 0.76, 2.60 and 9.78 mg/m 3 Nose-only inhalation exposure system 6 h/day 5 days Recovery for 1, 3, and 21 days , No significant body or organ weight changes No effects on: blood biochemistry and haematology, bronchoalveolar lavage fluid inflammatory markers No effects on bronchoalveolar lavage fluid lymphocytes, macrophages, or polymorphonuclear cells Spontaneous clearance of graphene oxide-ingested alveolar macrophages No histopathological lesions in liver and kidneys , Kim et al. . .. 3 , Graphene platelets (thicknesses, ranging from 0.350 to 0.380 nm, 96% carbon, 4% oxygen, 750 m 2 /g surface area of particles, 0.2 g/ml, < 2 μm ave
Concentration Assay:Article Title: Case study: risk associated to wearing silver or graphene nanoparticle-coated facemasks for protection against COVID-19
Article Snippet: in diameter (presumably GQD-PEG bioaccumulation) Blood biochemistry and haematology suggest no obvious toxicity of GQD-PEG , Chong et al. . .. 2 , Graphene oxide nanopowder (thickness 1 ~ 2 atom layer) Sprague–Dawley rats 15 males/group 0, 0.76, 2.60 and 9.78 mg/m 3 Nose-only inhalation exposure system 6 h/day 5 days Recovery for 1, 3, and 21 days , No significant body or organ weight changes No effects on: blood biochemistry and haematology, bronchoalveolar lavage fluid inflammatory markers No effects on bronchoalveolar lavage fluid lymphocytes, macrophages, or polymorphonuclear cells Spontaneous clearance of graphene oxide-ingested alveolar macrophages No histopathological lesions in liver and kidneys , Kim et al. . .. 3 , Graphene platelets (thicknesses, ranging from 0.350 to 0.380 nm, 96% carbon, 4% oxygen, 750 m 2 /g surface area of particles, 0.2 g/ml, < 2 μm ave
Zeta Potential Analyzer:Article Title: Case study: risk associated to wearing silver or graphene nanoparticle-coated facemasks for protection against COVID-19
Article Snippet: in diameter (presumably GQD-PEG bioaccumulation) Blood biochemistry and haematology suggest no obvious toxicity of GQD-PEG , Chong et al. . .. 2 , Graphene oxide nanopowder (thickness 1 ~ 2 atom layer) Sprague–Dawley rats 15 males/group 0, 0.76, 2.60 and 9.78 mg/m 3 Nose-only inhalation exposure system 6 h/day 5 days Recovery for 1, 3, and 21 days , No significant body or organ weight changes No effects on: blood biochemistry and haematology, bronchoalveolar lavage fluid inflammatory markers No effects on bronchoalveolar lavage fluid lymphocytes, macrophages, or polymorphonuclear cells Spontaneous clearance of graphene oxide-ingested alveolar macrophages No histopathological lesions in liver and kidneys , Kim et al. . .. 3 , Graphene platelets (thicknesses, ranging from 0.350 to 0.380 nm, 96% carbon, 4% oxygen, 750 m 2 /g surface area of particles, 0.2 g/ml, < 2 μm ave
In Vitro:Article Title: Case study: risk associated to wearing silver or graphene nanoparticle-coated facemasks for protection against COVID-19
Article Snippet: in diameter (presumably GQD-PEG bioaccumulation) Blood biochemistry and haematology suggest no obvious toxicity of GQD-PEG , Chong et al. . .. 2 , Graphene oxide nanopowder (thickness 1 ~ 2 atom layer) Sprague–Dawley rats 15 males/group 0, 0.76, 2.60 and 9.78 mg/m 3 Nose-only inhalation exposure system 6 h/day 5 days Recovery for 1, 3, and 21 days , No significant body or organ weight changes No effects on: blood biochemistry and haematology, bronchoalveolar lavage fluid inflammatory markers No effects on bronchoalveolar lavage fluid lymphocytes, macrophages, or polymorphonuclear cells Spontaneous clearance of graphene oxide-ingested alveolar macrophages No histopathological lesions in liver and kidneys , Kim et al. . .. 3 , Graphene platelets (thicknesses, ranging from 0.350 to 0.380 nm, 96% carbon, 4% oxygen, 750 m 2 /g surface area of particles, 0.2 g/ml, < 2 μm ave
In Vivo:Article Title: Case study: risk associated to wearing silver or graphene nanoparticle-coated facemasks for protection against COVID-19
Article Snippet: in diameter (presumably GQD-PEG bioaccumulation) Blood biochemistry and haematology suggest no obvious toxicity of GQD-PEG , Chong et al. . .. 2 , Graphene oxide nanopowder (thickness 1 ~ 2 atom layer) Sprague–Dawley rats 15 males/group 0, 0.76, 2.60 and 9.78 mg/m 3 Nose-only inhalation exposure system 6 h/day 5 days Recovery for 1, 3, and 21 days , No significant body or organ weight changes No effects on: blood biochemistry and haematology, bronchoalveolar lavage fluid inflammatory markers No effects on bronchoalveolar lavage fluid lymphocytes, macrophages, or polymorphonuclear cells Spontaneous clearance of graphene oxide-ingested alveolar macrophages No histopathological lesions in liver and kidneys , Kim et al. . .. 3 , Graphene platelets (thicknesses, ranging from 0.350 to 0.380 nm, 96% carbon, 4% oxygen, 750 m 2 /g surface area of particles, 0.2 g/ml, < 2 μm ave
Positive Control:Article Title: Case study: risk associated to wearing silver or graphene nanoparticle-coated facemasks for protection against COVID-19
Article Snippet: in diameter (presumably GQD-PEG bioaccumulation) Blood biochemistry and haematology suggest no obvious toxicity of GQD-PEG , Chong et al. . .. 2 , Graphene oxide nanopowder (thickness 1 ~ 2 atom layer) Sprague–Dawley rats 15 males/group 0, 0.76, 2.60 and 9.78 mg/m 3 Nose-only inhalation exposure system 6 h/day 5 days Recovery for 1, 3, and 21 days , No significant body or organ weight changes No effects on: blood biochemistry and haematology, bronchoalveolar lavage fluid inflammatory markers No effects on bronchoalveolar lavage fluid lymphocytes, macrophages, or polymorphonuclear cells Spontaneous clearance of graphene oxide-ingested alveolar macrophages No histopathological lesions in liver and kidneys , Kim et al. . .. 3 , Graphene platelets (thicknesses, ranging from 0.350 to 0.380 nm, 96% carbon, 4% oxygen, 750 m 2 /g surface area of particles, 0.2 g/ml, < 2 μm ave
Activation Assay:Article Title: Case study: risk associated to wearing silver or graphene nanoparticle-coated facemasks for protection against COVID-19
Article Snippet: in diameter (presumably GQD-PEG bioaccumulation) Blood biochemistry and haematology suggest no obvious toxicity of GQD-PEG , Chong et al. . .. 2 , Graphene oxide nanopowder (thickness 1 ~ 2 atom layer) Sprague–Dawley rats 15 males/group 0, 0.76, 2.60 and 9.78 mg/m 3 Nose-only inhalation exposure system 6 h/day 5 days Recovery for 1, 3, and 21 days , No significant body or organ weight changes No effects on: blood biochemistry and haematology, bronchoalveolar lavage fluid inflammatory markers No effects on bronchoalveolar lavage fluid lymphocytes, macrophages, or polymorphonuclear cells Spontaneous clearance of graphene oxide-ingested alveolar macrophages No histopathological lesions in liver and kidneys , Kim et al. . .. 3 , Graphene platelets (thicknesses, ranging from 0.350 to 0.380 nm, 96% carbon, 4% oxygen, 750 m 2 /g surface area of particles, 0.2 g/ml, < 2 μm ave
Negative Control:Article Title: Case study: risk associated to wearing silver or graphene nanoparticle-coated facemasks for protection against COVID-19
Article Snippet: in diameter (presumably GQD-PEG bioaccumulation) Blood biochemistry and haematology suggest no obvious toxicity of GQD-PEG , Chong et al. . .. 2 , Graphene oxide nanopowder (thickness 1 ~ 2 atom layer) Sprague–Dawley rats 15 males/group 0, 0.76, 2.60 and 9.78 mg/m 3 Nose-only inhalation exposure system 6 h/day 5 days Recovery for 1, 3, and 21 days , No significant body or organ weight changes No effects on: blood biochemistry and haematology, bronchoalveolar lavage fluid inflammatory markers No effects on bronchoalveolar lavage fluid lymphocytes, macrophages, or polymorphonuclear cells Spontaneous clearance of graphene oxide-ingested alveolar macrophages No histopathological lesions in liver and kidneys , Kim et al. . .. 3 , Graphene platelets (thicknesses, ranging from 0.350 to 0.380 nm, 96% carbon, 4% oxygen, 750 m 2 /g surface area of particles, 0.2 g/ml, < 2 μm ave
Control:Article Title: Case study: risk associated to wearing silver or graphene nanoparticle-coated facemasks for protection against COVID-19
Article Snippet: in diameter (presumably GQD-PEG bioaccumulation) Blood biochemistry and haematology suggest no obvious toxicity of GQD-PEG , Chong et al. . .. 2 , Graphene oxide nanopowder (thickness 1 ~ 2 atom layer) Sprague–Dawley rats 15 males/group 0, 0.76, 2.60 and 9.78 mg/m 3 Nose-only inhalation exposure system 6 h/day 5 days Recovery for 1, 3, and 21 days , No significant body or organ weight changes No effects on: blood biochemistry and haematology, bronchoalveolar lavage fluid inflammatory markers No effects on bronchoalveolar lavage fluid lymphocytes, macrophages, or polymorphonuclear cells Spontaneous clearance of graphene oxide-ingested alveolar macrophages No histopathological lesions in liver and kidneys , Kim et al. . .. 3 , Graphene platelets (thicknesses, ranging from 0.350 to 0.380 nm, 96% carbon, 4% oxygen, 750 m 2 /g surface area of particles, 0.2 g/ml, < 2 μm ave
Single Cell Gel Electrophoresis:Article Title: Case study: risk associated to wearing silver or graphene nanoparticle-coated facemasks for protection against COVID-19
Article Snippet: in diameter (presumably GQD-PEG bioaccumulation) Blood biochemistry and haematology suggest no obvious toxicity of GQD-PEG , Chong et al. . .. 2 , Graphene oxide nanopowder (thickness 1 ~ 2 atom layer) Sprague–Dawley rats 15 males/group 0, 0.76, 2.60 and 9.78 mg/m 3 Nose-only inhalation exposure system 6 h/day 5 days Recovery for 1, 3, and 21 days , No significant body or organ weight changes No effects on: blood biochemistry and haematology, bronchoalveolar lavage fluid inflammatory markers No effects on bronchoalveolar lavage fluid lymphocytes, macrophages, or polymorphonuclear cells Spontaneous clearance of graphene oxide-ingested alveolar macrophages No histopathological lesions in liver and kidneys , Kim et al. . .. 3 , Graphene platelets (thicknesses, ranging from 0.350 to 0.380 nm, 96% carbon, 4% oxygen, 750 m 2 /g surface area of particles, 0.2 g/ml, < 2 μm ave
|
